Associations between cognitive function and work productivity in bipolar disorder patients: An observational study.

Associations between cognitive function and work productivity in bipolar disorder patients: An observational study. - Associations between cognitive function and work productivity in bipolar disorder patients: An observational study.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051519

Enrollment

300

Registered

2023-07-04

Start date

2023-07-07

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar disorder

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Bipolar patients registered with QLife attending a medical institution at the time of the first questionnaire survey 2.Patients aged 18 years or more and under 60 years at the time of informed consent 3.Patients who are employed or on temporary retirement 4.Patients who are able to complete the questionnaire via the website at the time of assessment 5.Patients who have given their consent to participate in this study

Exclusion criteria

Exclusion criteria: 1.Patients who do not plan to return to work or find employment in the next one year 2.Hospitalized patients 3.Patients diagnosed with dementia

Design outcomes

Primary

Measure	Time frame
Change in cognitive function and work productivity from baseline to 48 weeks	—

Secondary

Measure	Time frame
(1) Change in cognitive function and each assessment index (from baseline to the time of each assessment) (2) Change in each assessment index in the improved cognitive function group and the worsened or unchanged cognitive function group at 12 weeks after baseline (from 12 weeks to the time of each assessment) (3) Change in each assessment index in the mild cognitive disfunction group and the moderate to severe cognitive disfunction group at baseline (from baseline to each time of assessment) (4) Change in each assessment index in the mild cognitive disfunction group and the moderate to severe cognitive disfunction group at 12 weeks after baseline (from 12 weeks to the time of each assessment) (5) Cognitive function and each assessment index at baseline (6) Patient background at baseline	—

Measure

Time frame

(1) Change in cognitive function and each assessment index (from baseline to the time of each assessment) (2) Change in each assessment index in the improved cognitive function group and the worsened or unchanged cognitive function group at 12 weeks after baseline (from 12 weeks to the time of each assessment) (3) Change in each assessment index in the mild cognitive disfunction group and the moderate to severe cognitive disfunction group at baseline (from baseline to each time of assessment) (4) Change in each assessment index in the mild cognitive disfunction group and the moderate to severe cognitive disfunction group at 12 weeks after baseline (from 12 weeks to the time of each assessment) (5) Cognitive function and each assessment index at baseline (6) Patient background at baseline

—

Countries

Japan

Contacts

Public ContactKoichiro Yamamoto

Mebix, Inc. Patient Outcome Team, Medical Science & Writing Group

clinical-research-dmq23@m3.com0120-37-4089

Outcome results